Fewer than 4 quarters available; TTM falls back to the latest annual figure.
Financials are reported in GBP; the price is in USD (the listing's quote basis differs from the reporting currency — an ADR over a non-USD reporter, or a native venue quoting in a sub-unit like pence). Price-based valuation (market cap, P/E, EV multiples, yields, WACC, and the market-cap-dependent Altman/Merton scores) is suppressed to avoid a cross-currency number. Currency-neutral ratios and returns are unaffected.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
P/E
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
10.2%
—
no band (30 mo · 3 distinct)
—
—
3.5%
30 · 3
7.9%
—
no band (30 mo · 3 distinct)
—
—
6.2%
30 · 3
15.1%
9.8%
no band (42 mo · 4 distinct)
—
—
3.2%
42 · 4
6.6%
9.1%
no band (40 mo · 39 distinct)
—
—
15.3%
40 · 39
EPS Growth 3Y
17.2%
only 2 monthly observations — under the 12-month floor for a series line. P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Sales Growth 3Y
0.5%
only 6 monthly observations — under the 12-month floor for a series line.
Market Cap
—
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
ROE (point-in-time)Materials median, same monthshaded = own p25–p75 · right-edge tick = today
shown for reference only — the reconstructed distribution did not clear the band gate, so no rank is quoted.
Multiple-implied price ladder · Full
Filed earnings only.
no P/E ladder — P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Ladder not drawn for this name — the reason is above.ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Covered pool$680.44B +3.0%/yr 2020→2025Concentration453 of 10,000fragmented · top 3 hold 28.3% · −29 pts since 2020HLN2.2% · rank 13 of 119 · −0.1pp over 5y· CV 0.10 · σ 0.2pp
Who holds the poolCY2025 · bars scaled to the largest member
Growth, restated as sharewhere each pace has to END UP, by 2030
Its own realised pace2.2% → 1.9%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
HLN share over time6 published years
Calendar year
2020
2021
2022
2023
2024
2025
Share of covered pool
2.2%
1.7%
1.6%
1.9%
2.0%
2.2%
coverage: 116 of the 126 members that…
Share of covered industry revenue · n=119 in Chemicals · CY2025 pool · built 2026-08-19 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
